- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01458509
Feasibility and Psychometric Properties of Paper vs. Web vs. Automated Telephone Administration of Patient Reported Outcome Surveys
A Comparison of the Feasibility and Psychometric Properties of Paper vs. Web vs. Automated Telephone Administration of Patient Reported Outcome Surveys
It can be difficult to obtain the perspective of patients who have had bowel surgery. This study is being done because the investigators are trying to find out whether patient-reported outcomes, (results reported to investigators by the patient), on a regular basis, will help the investigators provide better patient care and symptom management.
Therefore, the purpose of this study is to determine if it is possible and if it is useful to their medical care for patients who have had bowel surgery to complete surveys about their symptoms on a regular basis. In this study the surveys are completed from home, by web or by telephone, every month for 6 months. The results of this study will guide the design of large research studies on cancer-related bowel function.
The purpose of this study is to develop a bowel function questionnaire for patients with colorectal cancer. The questionnaire will be used in future clinical trials to assess bowel function.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
New York
-
New York, New York, United States, 10065
- Memorial Sloan-Kettering Cancer Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
Aim 1:
- Stage I-III rectal cancer
- Post sphincter preserving surgery with restoration of bowel continuity within last 4-6 weeks at MSKCC.
- Access to web and email from home
- Web avidity (≥2 uses of email/week)
- Able to read and write in English
- Age ≥ 18
Aim 2:
- Stage I-III colon and rectal cancer
- Post surgical resection of primary tumor at MSKCC
- Access to web and email from home
- Web avidity (≥2 uses of email/week)
- Able to read and write in English
- Age ≥ 18
Exclusion Criteria:
Aim 1:
- Metastatic disease - Auditory, visual or motor impairment that would preclude ability to use telephone and/or computer.
- Stoma
- Participated in Aim 2
- Definitive SPS = Transanal Excision (TAE) or Transanal Endoscopic Microsurgery (TEM)
Aim 2:
- Metastatic disease - Auditory, visual or motor impairment that would preclude ability to use telephone and/or computer.
- Stoma
- Participated in Aim 1
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
IVRS ( interactive voice response system) EASP
Telephone Group with Nurse Intervention
|
IVRS: An interactive voice response system (IVRS) is an automated telephone platform.
The IVRS system will allow the participant to complete the survey when they receive the call and/or to call the system within the survey window to complete the survey.
In each group, administration of a survey including the BFI, PRO-CTCAE sexual function items, and QOL LASA and in each group, the survey will be conducted once a month over a six-month period.
The intervention will be an email alert to study personnel (EASP).
Patients randomized to EASP will receive a phone call if their bowel function by the clinical office nurse if the study personnel determine that the patient's BFI, as reported on the monthly survey, is less than 53 (lowest quartile scores).
Interventions that may occur include dietary and/or medication advice at the discretion of the office staff.
Web: Study participants will be sent an email containing a link to the web survey.
The participants will click on the link and complete the survey.
Study participants may also login to the web survey independent of the link received via email.
In each group, administration of a survey including the BFI, PRO-CTCAE sexual function items, and QOL LASA and in each group, the survey will be conducted once a month over a six-month period.
Patients randomized to EASP will receive a phone call if their bowel function by the clinical office nurse if the study personnel determine that the patient's BFI, as reported on the monthly survey, is less than 53 (lowest quartile scores).
Interventions that may occur include dietary and/or medication advice at the discretion of the office staff.
IVRS: An interactive voice response system (IVRS) is an automated telephone platform.
The IVRS system will allow the participant to complete the survey when they receive the call and/or to call the system within the survey window to complete the survey.
In each group, administration of a survey including the BFI, PRO-CTCAE sexual function items, and QOL LASA and in each group, the survey will be conducted once a month over a six-month period.
This group will not get a phone call.
|
Web EASP
Web Group with Nurse Intervention
|
IVRS: An interactive voice response system (IVRS) is an automated telephone platform.
The IVRS system will allow the participant to complete the survey when they receive the call and/or to call the system within the survey window to complete the survey.
In each group, administration of a survey including the BFI, PRO-CTCAE sexual function items, and QOL LASA and in each group, the survey will be conducted once a month over a six-month period.
The intervention will be an email alert to study personnel (EASP).
Patients randomized to EASP will receive a phone call if their bowel function by the clinical office nurse if the study personnel determine that the patient's BFI, as reported on the monthly survey, is less than 53 (lowest quartile scores).
Interventions that may occur include dietary and/or medication advice at the discretion of the office staff.
Web: Study participants will be sent an email containing a link to the web survey.
The participants will click on the link and complete the survey.
Study participants may also login to the web survey independent of the link received via email.
In each group, administration of a survey including the BFI, PRO-CTCAE sexual function items, and QOL LASA and in each group, the survey will be conducted once a month over a six-month period.
Patients randomized to EASP will receive a phone call if their bowel function by the clinical office nurse if the study personnel determine that the patient's BFI, as reported on the monthly survey, is less than 53 (lowest quartile scores).
Interventions that may occur include dietary and/or medication advice at the discretion of the office staff.
IVRS: An interactive voice response system (IVRS) is an automated telephone platform.
The IVRS system will allow the participant to complete the survey when they receive the call and/or to call the system within the survey window to complete the survey.
In each group, administration of a survey including the BFI, PRO-CTCAE sexual function items, and QOL LASA and in each group, the survey will be conducted once a month over a six-month period.
This group will not get a phone call.
|
IVRS ( interactive voice response system) No EASP
Telephone Group without nurse intervention
|
IVRS: An interactive voice response system (IVRS) is an automated telephone platform.
The IVRS system will allow the participant to complete the survey when they receive the call and/or to call the system within the survey window to complete the survey.
In each group, administration of a survey including the BFI, PRO-CTCAE sexual function items, and QOL LASA and in each group, the survey will be conducted once a month over a six-month period.
The intervention will be an email alert to study personnel (EASP).
Patients randomized to EASP will receive a phone call if their bowel function by the clinical office nurse if the study personnel determine that the patient's BFI, as reported on the monthly survey, is less than 53 (lowest quartile scores).
Interventions that may occur include dietary and/or medication advice at the discretion of the office staff.
Web: Study participants will be sent an email containing a link to the web survey.
The participants will click on the link and complete the survey.
Study participants may also login to the web survey independent of the link received via email.
In each group, administration of a survey including the BFI, PRO-CTCAE sexual function items, and QOL LASA and in each group, the survey will be conducted once a month over a six-month period.
Patients randomized to EASP will receive a phone call if their bowel function by the clinical office nurse if the study personnel determine that the patient's BFI, as reported on the monthly survey, is less than 53 (lowest quartile scores).
Interventions that may occur include dietary and/or medication advice at the discretion of the office staff.
IVRS: An interactive voice response system (IVRS) is an automated telephone platform.
The IVRS system will allow the participant to complete the survey when they receive the call and/or to call the system within the survey window to complete the survey.
In each group, administration of a survey including the BFI, PRO-CTCAE sexual function items, and QOL LASA and in each group, the survey will be conducted once a month over a six-month period.
This group will not get a phone call.
|
Web No EASP
Web Group without nurse intervention
|
Web: Study participants will be sent an email containing a link to the web survey.
The participants will click on the link and complete the survey.
Study participants may also login to the web survey independent of the link received via email.
In each group, administration of a survey including the BFI, PRO-CTCAE sexual function items, and QOL LASA and in each group, the survey will be conducted once a month over a six-month period.
This group will not receive a phone call.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
clinically useful to collect patient-reported data
Time Frame: 6 months
|
using electronic methods (interactive voice response system (IVRS) or web interface)
|
6 months
|
feasibility of electronic PRO assessment
Time Frame: 2 years
|
we define feasibility as being the completion of 4/6 surveys.
A complete survey is defined as having responses to 17/24 items (70%) on the survey.
The administration mode will be deemed feasible if >=70% of patients complete 4/6 surveys.
|
2 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
psychometric equivalence
Time Frame: 2 years
|
Relevant in colorectal cancer trials via three different modes of administration: Web, IVRS, paper.
The primary interest is the psychometric properties of the total score and subscale scores of the BFI, however individual items scores will be examined as well.
|
2 years
|
problems people experience
Time Frame: 2 years
|
With bowel function, bladder function, and sexual function over the course of treatment for rectal cancer and to identify the types of information that would be helpful to future patients.
Patients who were enrolled in Aim 1 will be asked to participate in a 30-45 minute telephone interview.
A total of 20 interviews will be conducted.
|
2 years
|
Collaborators and Investigators
Investigators
- Principal Investigator: Julio Garcia-Aguilar, MD, PhD, Memorial Sloan Kettering Cancer Center
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 11-101
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Rectal Cancer
-
Ohio State University Comprehensive Cancer CenterNovartis Pharmaceuticals; National Comprehensive Cancer NetworkCompletedStage IIA Rectal Cancer | Stage IIB Rectal Cancer | Stage IIC Rectal Cancer | Stage IIIA Rectal Cancer | Stage IIIB Rectal Cancer | Stage IIIC Rectal Cancer | Recurrent Rectal CancerUnited States
-
M.D. Anderson Cancer CenterRecruitingEvaluation of Quality of Life and Utilities Following Surgical Treatment of Stage I-IV Rectal CancerStage III Rectal Cancer AJCC v8 | Stage IIIA Rectal Cancer AJCC v8 | Stage IIIB Rectal Cancer AJCC v8 | Stage IIIC Rectal Cancer AJCC v8 | Stage IV Rectal Cancer AJCC v8 | Stage IVA Rectal Cancer AJCC v8 | Stage IVB Rectal Cancer AJCC v8 | Stage IVC Rectal Cancer AJCC v8 | Rectal Adenocarcinoma | Stage... and other conditionsUnited States
-
OHSU Knight Cancer InstituteNatera, Inc.RecruitingEstablishing a ctDNA Biomarker to Improve Organ Preserving Strategies in Patients With Rectal CancerStage III Rectal Cancer AJCC v8 | Stage IIIA Rectal Cancer AJCC v8 | Stage IIIB Rectal Cancer AJCC v8 | Stage IIIC Rectal Cancer AJCC v8 | Rectal Adenocarcinoma | Stage IIA Rectal Cancer AJCC v8 | Stage IIB Rectal Cancer AJCC v8 | Stage II Rectal Cancer AJCC v8 | Stage IIC Rectal Cancer AJCC v8United States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingStage III Rectal Cancer AJCC v8 | Stage IIIA Rectal Cancer AJCC v8 | Stage IIIB Rectal Cancer AJCC v8 | Stage IIIC Rectal Cancer AJCC v8 | Rectal Adenocarcinoma | Stage IIA Rectal Cancer AJCC v8 | Stage IIB Rectal Cancer AJCC v8 | Stage II Rectal Cancer AJCC v8 | Stage IIC Rectal Cancer AJCC v8United States
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)WithdrawnStage IIA Rectal Cancer | Stage IIB Rectal Cancer | Stage IIC Rectal Cancer | Stage IIIA Rectal Cancer | Stage IIIB Rectal Cancer | Rectal AdenocarcinomaUnited States
-
OHSU Knight Cancer InstituteOregon Health and Science University; Taiho Pharmaceutical Co., Ltd.RecruitingStage III Rectal Cancer AJCC v8 | Stage IIIA Rectal Cancer AJCC v8 | Stage IIIB Rectal Cancer AJCC v8 | Stage IIIC Rectal Cancer AJCC v8 | Rectal Adenocarcinoma | Stage IIA Rectal Cancer AJCC v8 | Stage IIB Rectal Cancer AJCC v8United States
-
Jonsson Comprehensive Cancer CenterNatera, Inc.; The Joseph Drown FoundationRecruitingStage III Rectal Cancer AJCC v8 | Stage IIIA Rectal Cancer AJCC v8 | Stage IIIB Rectal Cancer AJCC v8 | Stage IIIC Rectal Cancer AJCC v8 | Rectal Adenocarcinoma | Stage IIA Rectal Cancer AJCC v8 | Stage IIB Rectal Cancer AJCC v8 | Stage II Rectal Cancer AJCC v8 | Stage IIC Rectal Cancer AJCC v8 | Locally...United States
-
Case Comprehensive Cancer CenterCompletedStage IIA Rectal Cancer | Stage IIB Rectal Cancer | Stage IIC Rectal Cancer | Stage IIIA Rectal Cancer | Stage IIIB Rectal Cancer | Stage IIIC Rectal Cancer | Stage IIIA Colon Cancer | Stage IIIB Colon Cancer | Stage IIIC Colon Cancer | Recurrent Colon Cancer | Recurrent Rectal Cancer | Stage IVA Colon Cancer | Stage IVA Rectal Cancer and other conditionsUnited States
-
City of Hope Medical CenterWithdrawnRecurrent Rectal Cancer | Stage I Rectal Cancer | Stage II Rectal Cancer | Stage III Rectal Cancer
-
National Cancer Institute (NCI)TerminatedMetastatic Rectal Adenocarcinoma | Rectal Adenocarcinoma | Stage III Rectal Cancer AJCC v7 | Stage IIIA Rectal Cancer AJCC v7 | Stage IIIB Rectal Cancer AJCC v7 | Stage IIIC Rectal Cancer AJCC v7 | Stage IV Rectal Cancer AJCC v7 | Stage IVA Rectal Cancer AJCC v7 | Stage IVB Rectal Cancer AJCC v7 | Locally...United States
Clinical Trials on surveys
-
University of MichiganNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Not yet recruiting
-
RANDClaremont Graduate UniversityCompleted
-
Elysium HealthUniversity of OxfordNot yet recruitingBiological Aging
-
H. Lee Moffitt Cancer Center and Research InstituteCompletedMuscle-Invasive Bladder Carcinoma | Bladder Cancer Stage II | Bladder Cancer Stage III | Bladder Cancer Stage IVUnited States
-
University Hospital, AngersCompletedOpioid-Related Disorders | Critically Ill | Pain, ChronicFrance
-
Mayo ClinicCompletedCesarean SectionUnited States
-
Hospital for Special Surgery, New YorkCompletedPain, Postoperative | TSA | BruiseUnited States
-
Northwestern UniversityCompleted
-
Richmond University Medical CenterRecruiting